Prenetics Global
PRE
9 hedge funds and large institutions have $6.6M invested in Prenetics Global in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
48% more capital invested
Capital invested by funds: $4.47M → $6.6M (+$2.13M)
13% more funds holding
Funds holding: 8 → 9 (+1)
0.26% more ownership
Funds ownership: 10.45% → 10.71% (+0.26%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$73K |
| 2 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$59.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.21K |
| 2 |
APC
Aspire Private Capital
Cornelius,
North Carolina
|
-$462 |
PRE Hedge Fund Activity: Q4 2024 in Review
9 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Prenetics Global (PRE) for Q4 2024, worth a combined $6.6M — up 48% from $4.47M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PRE positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $73K. The largest seller was Morgan Stanley, cutting an estimated $1.21K.
- 9 institutional investors held Prenetics Global (PRE) as of Q4 2024, up from 8 in Q3 2024.
- Funds reported $6.6M of Prenetics Global stock for Q4 2024, up 48% quarter-over-quarter.
- 2 funds opened new Prenetics Global positions in Q4 2024 and 1 closed out, a net change of +1 holder.
- The largest Prenetics Global buyer in Q4 2024 was UBS Group, an estimated $73K added.
- The largest Prenetics Global seller in Q4 2024 was Morgan Stanley, an estimated $1.21K sold.
Based on aggregated 13F filings for Q4 2024.